Literature DB >> 18039438

[Elevated risk of HIV infection in homosexual men even after contact with the health system].

Alicia Barrasa1, José Manuel Lorenzo, Luis María Sáez de Vicuña, Pilar Saladié, Encarnación Arellano, Guendane Larrañaga, Esperanza Castro, Araceli Losas, María Angeles Neira, María Mar Cuesta, Antonia Mendo, Jesús Castilla.   

Abstract

OBJECTIVE: To determine the incidence of HIV seroconversion and to evaluate the characteristics associated with a greater risk of seroconversion in homosexual men in the period 2000-2003.
METHODS: We performed a dynamic cohort study of all homosexual men tested for HIV in 20 ambulatory care centers specialized in diagnosing HIV, located in 19 cities in Spain. The characteristics of the men were analyzed and the seroconversion incidence rate was calculated among those who were followed up.
RESULTS: In the period 2000-2003, a total of 10,189 persons-year of follow-up were accumulated and 167 seroconversions were diagnosed with a seroconversion incidence rate of 16.4 per 1,000 persons-year. Most of the seroconversions (63%) occurred in men younger than 30 years old. The seroconversion rate was higher among homosexual men from Latin America and sub-Saharan Africa than among Spanish men.
CONCLUSIONS: In Spain, the risk of HIV transmission among men who have sex with men is still high. Therefore, this population continues to be a high priority group in HIV prevention. A proportion of HIV diagnoses among immigrants concern infections acquired after their arrival to Spain, probably due to conditions of greater social vulnerability. Reinforcing and renewing prevention strategies directed at this population would be timely.

Entities:  

Mesh:

Year:  2007        PMID: 18039438     DOI: 10.1016/s1130-8621(07)71822-3

Source DB:  PubMed          Journal:  Enferm Clin        ISSN: 1130-8621


  1 in total

1.  Sexual diversity, social inclusion and HIV/AIDS.

Authors:  Carlos F Cáceres; Peter Aggleton; Jerome T Galea
Journal:  AIDS       Date:  2008-08       Impact factor: 4.177

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.